Development and validation of a novel bleeding risk prediction tool for aspirin users with a low body mass index
Abstract Aspirin is commonly utilized in the management and prevention of various diseases. However, in specific individuals, particularly those with low body mass index (BMI), aspirin can elevate the risk of bleeding. Achieving a delicate equilibrium between the desirable antiplatelet effects and p...
Saved in:
Main Authors: | Lu Yifang, Lei Wanlin, Wang Maofeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88327-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of aspirin in cancer prevention
by: Meng Sun, et al.
Published: (2024-01-01) -
Development of a green and rapid ethanol-based HPLC assay for aspirin tablets and feasibility evaluation of domestically produced bioethanol in Thailand as a sustainable mobile phase
by: Thanayutsiri Thana, et al.
Published: (2025-02-01) -
Determination of Acetyl Salicylic Acid in Aspirin tablets
by: Lana Mohammed Ali, et al.
Published: (2019-12-01) -
Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study
by: Yaqin Dong, et al.
Published: (2025-02-01) -
Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
by: Takao Ohmori, et al.
Published: (2025-02-01)